Robaxin relieves muscle pain caused by sprains and strains, treats skeletal muscle spasm. Before using the medication please consult with your doctor to avoid overdose Robaxin and not cause a complication of the disease. Robaxin may cause drowsiness or dizziness, which may impair their ability to operate motor vehicles or machinery.
Pharmacological group of Robaxin
Before using the medication please consult with your doctor to avoid overdose Robaxin and not cause a complication of the disease. Take it orally with or without food/milk.
The recommended dose for adults: is 2 tablets four times daily but therapeutic response has been achieved with doses as low as 1 tablet three times daily.
The nosological classification (ICD-10) of Robaxin
K21 Gastroesophageal reflux
K25 Gastric ulcer
K26 Duodenal Ulcer
K31.8.0 * atony stomach
K59.8.0 * intestinal atony
K82.8.0 * Dyskinesia of the gallbladder and biliary tract
K94 * Diagnosis of gastrointestinal diseases
R11 Nausea and vomiting
R14 Flatulence and related conditions
Z100 * CLASS XXII Surgical practice
Z51.0 course radiotherapy
Z51.1 Chemotherapy about tumors
Indications for use Robaxin
Nausea, vomiting, hiccups of various origins (in some cases it may be effective in vomiting caused by radiation therapy or receiving cytostatics), functional dyspepsia, gastro-oesophageal reflux disease, hypotension, and atony of the stomach and duodenum (including postoperative) , biliary dyskinesia, flatulence, exacerbation of gastric ulcer and duodenal ulcer (in the complex therapy), preparation for diagnostic gastrointestinal studies.
Contraindications of Robaxin
Hypersensitivity, bleeding from the gastrointestinal tract, stenosis of the pylorus, mechanical intestinal obstruction, perforation of the wall of the stomach or intestines (including state, when the gain of gastrointestinal motor activity is not desirable), glaucoma, pheochromocytoma (possible hypertensive crisis due to the release of catecholamines from the tumor) , epilepsy (severity and frequency of seizures may be increased), Parkinson’s disease and other extrapyramidal disorders (may increase), tumor, a young child up to 2 years (increased risk of dyskinetic syndrome).
Restrictions apply of Robaxin
Bronchial asthma (increases the risk of bronchospasm), hypertension (with on / in a possible deterioration due to the release of catecholamines), liver and / or kidney failure, advanced age, children under 14 years of age (for parenteral administration).
Side effects of Robaxin
From the nervous system and sensory organs: restlessness (10%), drowsiness (10%, often at high doses), unusual tiredness or weakness (10%). Extrapyramidal disorders, including acute dystonic reactions (0.2% at doses of 30-40 mg / day), such as convulsive twitching of facial muscles, trismus, opisthotonos, muscle hypertonicity, spasmodic torticollis, a spasm of extraocular muscles (including oculogyric crisis), rhythmic protrusion tongue, bulbar type of speech; rarely — stridor and dyspnea. Parkinsonian symptoms: bradykinesia, tremor, muscle rigidity — a manifestation of the dopamine-blocking action, the risk of children and adolescents increased in excess of the dose of 0.5 g / kg / day. Tardive dyskinesia, including involuntary movements of the tongue, bombast, uncontrolled chewing movements, uncontrolled movements of the arms and legs (see. Also «Precautions»). Insomnia, headache, dizziness, disorientation, depression (symptoms were moderate to severe degree and have included suicidal thoughts and suicide), anxiety, confusion, ringing in the ears; rarely — hallucinations. There are rare reports of development of neuroleptic malignant syndrome (hyperthermia, muscle rigidity, altered mental status, autonomic dysfunction).
Cardio-vascular system and blood (blood, hemostasis): hypotension / hypertension, tachycardia / bradycardia, fluid retention.
From the digestive tract: constipation / diarrhea, dry mouth; rarely — hepatotoxicity (jaundice, abnormal liver function indicators — if metoclopramide used in conjunction with other hepatotoxic drugs).
Allergic reactions: urticaria.
Other: frequent urination, urinary incontinence, chronic administration of high doses — gynecomastia, galactorrhea, menstrual disorders, asymptomatic weak congestion of the nasal mucosa, agranulocytosis.